SRI International has completed the expansion of its 40,000-sq.-ft. R&D facility in Harrisonburg, VA. SRI invested $2.8 million to build-out and enhance its bioscience research capabilities at SRI’s Shenandoah Valley (SRI SV) Center for Advanced Drug Research.  The new biomedical facilities include more than 2,500-sq.-ft. of lab and storage areas for preclinical research, drug discovery, and drug development programs. SRI SV focuses on basic research, including infectious diseases, me...